Recent reports in Science and Medicine for August 2003
Some
of these links are very transient and may expire within days of posting.
Some may require prior registration. Check-in and view frequently to avoid
missing great news items. I welcome any suggested articles. (email
link). "§" indicates
a faculty recommended article.
Medscape Expert Column:
New Perspectives on the Quality of Care: Reducing Medical Errors Through
Cultural Change and Clinical Transformation August 25, 2003
FDA approves Anakinra
(Kineret) for the reduction in signs and symptoms and slowing the progression
of structural damage in moderately to severely active rheumatoid arthritis,
in patients 18 years of age or older who have failed one or more disease
modifying antirheumatic drugs. August 25, 2003.
FDA Approves New Drug for Treatment of Erectile Dysfunction in Men [FDA
Talk Paper]
Cancer Genetics Program pinpoints gene that increases cancer risk by 26
percent [Eurekalert
report] of in process citation TGFBR1 *6A and Cancer Risk: A Meta-Analysis
of Seven Case-Control Studies. Kaklamani VG, et al. JCO
Sep 1 2003: 3236-3243.
Weekend
Reading
Dissecting the Helicobacter arsenal (The
Scientist news) Helicobacter pylori Vacuolating Cytotoxin Inhibits
T Lymphocyte Activation. Gebert B, et al.Science 2003; 301:1099-1102.
Efficacy of Sertraline in the Treatment of Children and Adolescents With
Major Depressive Disorder: Two Randomized Controlled Trials. Wagner et
al. JAMA.
2003;290:1033-1041.
Ultralow-Dose Micronized 17 -Estradiol and Bone Density and Bone Metabolism
in Older Women: A Randomized Controlled Trial. Prestwood et al. JAMA.
2003;290:1042-1048.
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset
Atrial Fibrillation in the Community: The Framingham Heart Study. Wang
et al. JAMA.
2003;290:1049-1056.
Provision of Pneumococcal Prophylaxis for Publicly Insured Children
With Sickle Cell Disease.Sox, et al. JAMA.
2003;290:1057-1061.
Methodological Differences in Clinical Trials Evaluating Nonpharmacological
and Pharmacological Treatments of Hip and Knee Osteoarthritis. Boutron,
et al. JAMA.
2003;290:1062-1070.
BRIEF REPORTS: D-Dimer Levels and Risk of Recurrent Venous Thromboembolism
Eichinger, et al. JAMA.
2003;290:1071-1074.
SPECIAL COMMUNICATIONS Ethics of Phase 1 Oncology Studies: Reexamining
the Arguments and Data. Agrawal and Emanuel. JAMA.
2003;290:1075-1082.
Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening
for All-Cause Mortality Shaw LJ, et al. Radiology
published online July 17, 2003, in September issue. [Coronary artery
calcium can be a warning sign of fatal cardiac event Eurekalert]
Differences in Medical Care and Disease Outcomes Among Black and White
Women With Heart Disease Jha AK, et al. Circulation
2003: published online before print August 25, 2003, 10.1161/01
Impact of Viral and Bacterial Burden on Cognitive Impairment in Elderly
Persons With Cardiovascular Diseases. Strandberg TE, et al.Stroke
published online August 14, 2003.
Mayo Clinic proceedings releases West Nile virus manuscript early [pdf
of manuscript: West Nile Virus: Epidemiology, Clinical Presentation,
Diagnosis and Prevention]
St. Jude Medical announces publication of results of its ADOPT-A trial
[Eurekalert
news]JACC
Prognostic Value of PET Using 18 F-FDG in Hodgkin’s Disease for Posttreatment
Evaluation Guay C, et al. J
Nucl Med 2003 44: 1225-1231.
Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart
Disease Events. Greenland P, et al. JAMA.
2003;290:891-897.
Prevalence of Conventional Risk Factors in Patients With Coronary Heart
Disease Khot UN, et al. JAMA.
2003;290:898-904.
Pediatric Drug Labeling: Improving the Safety and Efficacy of Pediatric
Therapies. JAMA. 2003;290:905-911.
Effect of a High-Fat Ketogenic Diet on Plasma Levels of Lipids, Lipoproteins,
and Apolipoproteins in Children JAMA. 2003;290:912-920.
Association of Funding and Conclusions in Randomized Drug Trials: A Reflection
of Treatment Effect or Adverse Events? Als-Nielsen B, et al. JAMA.
2003;290:921-928.
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical
Review of the Evidence. Hackam and Anand JAMA.
2003;290:932-940.
Association Between BRCA1 Mutations and Ratio of Female to Male Births
in Offspring of Families With Breast Cancer, Ovarian Cancer, or Both. de
la Hoya M, et al. JAMA. 2003;290:929-931.
SPECIAL COMMUNICATIONS Physician Discontent: Challenges and Opportunities
David Mechanic JAMA.
2003;290:941-946.
EDITORIALS: Major Risk Factors for Cardiovascular Disease: Debunking the "Only
50%" Myth. Canto and. Iskandrian JAMA.
2003;290:947-949.
THE PATIENT-PHYSICIAN RELATIONSHIP Patient-Physician Communication About
Out-of-Pocket Costs. JAMA. 2003;290:953-958.
A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute
Myocardial Infarction. H. R. Andersen and Others.N
Engl J Med 2003: 349: 733
Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome
of Chemotherapy for Acute Myeloid Leukemia. B. Löwenberg and Others N
Engl J Med 2003: 349: 743
A Chorionic Gonadotropin–Sensitive Mutation in the Follicle-Stimulating
Hormone Receptor as a Cause of Familial Gestational Spontaneous Ovarian Hyperstimulation
Syndrome
C. Vasseur and Others. N
Engl J Med 2003: 349: 753
Ovarian Hyperstimulation Syndrome Due to a Mutation in the Follicle-Stimulating
Hormone Receptor. G. Smits and Others. N
Engl J Med 2003: 349: 760
Costs of Health Care Administration in the United States and Canada. S.
Woolhandler, T. Campbell, and D. U. Himmelstein. N
Engl J Med 2003: 349: 768
Medical Progress: Congenital Adrenal Hyperplasia. P. W. Speiser and P.
C. White. N
Engl J Med 2003: 349:776
Review: Hematopoietic Growth Factors and the Future of Therapeutic Research
on Acute Myeloid Leukemia C. A. Schiffer. N
Engl J Med 2003: 349: 727
Primary Angioplasty for Acute Myocardial Infarction — Is It Worth
the Wait? A. K. Jacobs, N
Engl J Med 2003: 349: 798
The Costs of Health Care Administration in the United States and Canada — Questionable
Answers to a Questionable Question. H. J. Aaron. N Engl J Med 2003:
349: 801
August 22
NMEs Approved in Calendar Year 2003 to date (FDA
news)
Different patterns of N-acetylaspartate loss in subcortical ischemic vascular
dementia and AD Schuff N, et al. Neurology
2003 61: 358-364.
Toxic Protein Could Explain Alzheimer's And Lead To Breakthroughs { Eurekalert
news} Alzheimer's disease-affected brain: Presence of oligomeric A
ligands (ADDLs) suggests a molecular basis for reversible memory loss Gong
Y, et al. PNAS
published August 18, 2003
New Alzheimer projections add urgency to search for prevention, cure [Eurekalert
news] Alzheimer Disease in the US Population: Prevalence Estimates
Using the 2000 Census. Hebert LE, et al. Arch
Neurol. 2003;60:1119-1122.
Weekend
Reading
Researchers One Step Closer To Holy Grail Of Neurobiology (Science
Daily) from PNAS
Gastric Versus Post-Pyloric Feeding: A Systematic Review [Medscape
review of Critical Care 2003;7:
August 21
Randomized trial of the adenosine A 2A receptor antagonist istradefylline
in advanced PD Hauser RA, et al. Neurology
2003 61: 297-303. [Science
Daily news report: Study Shows New Drug Reduces Advanced Parkinson's
Disease Symptoms ]
FDA Approves New Drug for Treatment of Erectile Dysfunction in Men : FDA
News August 19, 2003.
The Effect of Endoscopic Therapy in Patients Receiving Omeprazole
for Bleeding Ulcers with Nonbleeding Visible Vessels or Adherent
Clots: A Randomized Comparison
Progression of Chronic Kidney Disease: The Role of Blood Pressure
Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition:
A Patient-Level Meta-Analysis
Obesity: Associations with Acute Mountain Sickness
Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection:
A Randomized, Placebo-Controlled Clinical Trial
Patient Safety and Medical Malpractice: A Case Study
Academia and Clinic : Evaluation of Abnormal Mammography Results
and Palpable Breast Abnormalities
Update in General Internal Medicine
August 20
Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan
Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension
(LIFE) Study. Okin PM, et al. Circulation
2003 108: 684 - 690.
Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently
of Body Weight in Mice.Barouch LA, et al.Circulation.
2003;108:754 . [Editorial: Leptin
A Novel Link Between Obesity, Diabetes, Cardiovascular Risk, and Ventricular
Hypertrophy. Sawsan Sader Circulation.
2003;108:644. ]
Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Inhibit
Platelet Activation Triggered by the Lipid Core of Atherosclerotic Plaques.
RotherE, et al.Circulation.
2003;108:741 [Editorial: Plaque Rupture, Lysophosphatidic Acid, and
Thrombosis. A. Spector Circulation.
2003;108:641 ]
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen H, et al. Arch
Neurol. 2003;60:1059-1064. and EDITORIAL: Nonsteroidal Anti-inflammatory
Drugs Protect Against Parkinson Neurodegeneration: Can an NSAID a Day Keep
Parkinson Disease Away? Arch
Neurol. 2003;60:1043-1044.
August 19
A self-administered screener for migraine in primary care: The ID Migraine
TM validation study Lipton RB, et al. Neurology
2003 61: 375-382
Long-term effect of a watch and wait policy versus immediate systemic
treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised
controlled trial. Ardeshna K M et al. Lancet
2003: 362:
Incidence of recurrent venous thromboembolism in relation to clinical
and thrombophilic risk factors: prospective cohort study. Baglin T,
et al.Lancet
2003; 362: 523-26
Role of HER2 in wound-induced breast carcinoma proliferation. Tagliabue
E, et al.
Impact of Aerobic Exercise Training on Age-Related Changes in Insulin Sensitivity
and Muscle Oxidative Capacity Short KR, et al.Diabetes
2003 52: 1888-1896. [Eurekalert
news: study finds people over 40 need frequent exercise to prevent or
treat Type 2 diabetes ]
Perspective: Childhood Leukemia -- Successes and Challenges for Survivors.
J.V. Simone
Perspective: Trial Design and Patient Safety -- The Debate Continues.
R. Steinbrook
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity
Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism.
C. Kearon and Others. N
Engl J Med 2003;349: 361- 369 :
Buller, H. R., Prins, M. H. (2003). Secondary Prophylaxis with Warfarin
for Venous Thromboembolism. N
Engl J Med 349: 702-704
Extended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic
Leukemia.C.-H. Pui and Others
Methotrexate versus Cyclosporine in Moderate-to-Severe Chronic Plaque
Psoriasis. V.M.R. Heydendael and Others
Current Concepts: Acute Cardiac Tamponade. D.H. Spodick
August 15
Review of the Centers for Disease Control and Prevention's Smallpox Vaccination
Program Implementation, Letter
Report from Institute of Medicine Published On: August 12, 2003
§Retrograde
Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS
Model. Kaspar BK, et al. Scinece 2003; 301: (subscribers
and Science
news release ). Gene therapy delays death in mouse with
symptoms of Lou Gehrig's disease (Eurekalert
news report). Gene Therapy Delays Death In Mouse With
Symptoms Of Lou Gehrig's Disease (Science
Daily news)
Creation Of New Neurons Critical To Antidepressant Action
In Mice (Science
Daily news)
From Cell
Phosphatidylinositol 4 Phosphate Regulates Targeting of Clathrin
Adaptor AP-1 Complexes to the Golgi. Ying JW, et al.Cell,
Vol 114, 299-310, 8 August 2003 Main regulator of membrane trafficking
not what researchers once thought, scientists discover (UTSWMC
news release)
Newly Identified Tumor Suppressor Cooperates With P53 To Protect
Mice Against Tumors (Science
Daily news).
Untangling the Brain: Enzyme counters Alzheimer's-like snarls (Science
News report)
Direct Observation of Requests for Clinical Services in Office Practice:
What Do Patients Want and Do They Get It? Kravitz, RL , et al. Arch
Intern Med. 2003;163:1673-1681.
Quality Assessment of a Collaborative Approach for Decreasing Drug-Related
Morbidity and Achieving Therapeutic Goals Isetts BJ, et al. Arch
Intern Med. 2003;163:1813-1820.
Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently
of Body Weight in Mice Barouch LA, et al. Circulation
2003 108: 754 - 759
This week's JAMA:
§Proposal
of the Physicians' Working Group for Single-Payer National Health Insurance.
The Physicians' Working Group for Single-Payer National Health Insurance. JAMA. 2003;290:798-805. and
Editorial: Universal Health Insurance—Let the Debate Resume Fein
R. JAMA.
2003;290:818-820. [Medscape
interview]
Impact of Medicare Coverage on Basic Clinical Services for Previously
Uninsured Adults McWilliams JM, et al. JAMA. 2003;290:757-764. and
editorial Small Steps or a Giant Leap for the Uninsured? Bindman AB
et al. JAMA. 2003;290:816-818.
Past exposure to sun, skin phenotype, and risk of multiple sclerosis:
case-control study. van der Mei IAF, et al. BMJ 2003;327:316
Acute low back pain: systematic review of its prognosis. Pengel LHM,
et al.BMJ 2003;327:323
Increased Risk of Achilles Tendon Rupture With Quinolone Antibacterial
Use, Especially in Elderly Patients Taking Oral Corticosteroids.van der Linden;PD,
et al. Arch
Intern Med. 2003;163:1801-1807.
Platelet/Endothelial Biomarkers in Depressed Patients Treated With the
Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events.
The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet
Substudy. Serebruany VL,et al. . Circulation
2003: published online before print August 11, 2003.
A prospective randomized comparison of loop recorders versus Holter monitors
in patients with syncope or presyncope Sivakumaran S, et al. A
J Med 2003: 115: 1-5
Waiting times, revascularization modality, and outcomes after acute myocardial
infarction at hospitals with and without on-site revascularization facilities
in Canada Alter DA, et al. JACC
2003; 42: 410-419 [Editorial: The early days after ST-segment elevation
acute myocardial infarction. pp. 420-423]
Percutaneous coronary interventions in octogenarians Sadeghi HM, et al. JACC
2003: 42: 428-432 [Editorial: Percutaneous coronary intervention
in octogenarians and the safety of glycoprotein IIb/IIIa inhibitors. pp.
433-436]
FDA Approves Axcan's Photofrin Esophagus Therapy (press and
FDA news releases)
Estrogen plus Progestin and the Risk of Coronary Heart Disease. J. E. Manson
et al.
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis
in Postmenopausal Women. H. N. Hodis et al.
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary
Dissection in Breast Cancer U. Veronesi et al.
Genomic Medicine: Ethical, Legal, and Social Implications of Genomic Medicine.
E. W. Clayton
Medical Progress: Adult Stem Cells for Tissue Repair — A New Therapeutic
Concept? M. Körbling and Z. Estrov
Mechanisms of Disease: Molecular Mechanisms of Amyloidosis G. Merlini
and V. Bellotti
From Presumed Benefit to Potential Harm — Hormone Therapy and Heart
Disease D. M. Herrington and T. D. Howard
Retrospective: Hormone-Replacement Therapy and Cardiovascular Diseases
J. Bailar
The Design of Trials Comparing Sentinel-Node Surgery and Axillary Resection.
D. Krag and T. Ashikaga
August 8
Detection and Verification of Mycobacterium avium subsp. paratuberculosis
in Fresh Ileocolonic Mucosal Biopsy Specimens from Individuals with and without
Crohn's Disease. Bull TJ, et al. J.
Clin. Microbiol. 2003. 41: 2915-2923.
Hepatic lipase expression in macrophages contributes to atherosclerosis
in apoE-deficient and LCAT-transgenic mice Nong Z, et al. J.
Clin. Invest. 2003 112: 367-378. (The
Scientist news Hepatic lipase expression in aortic macrophages contributes
to atherosclerosis )
Science graduates live long and prosper (New
Scientist)
Mouse studies reveal immune mechanism involved in bone loss caused by estrogen
deficiency (Eurekalert
news from PNAS
Mutation may help cause acute myeloid leukemia . (Eurekalert
news) NIH/National Cancer Institute, Leukemia and Lymphoma Society
Relation of Serum Ascorbic Acid to Helicobacter pylori Serology
in US Adults: The Third National Health and Nutrition Examination Survey.
Simon JA, et al. J
Am Coll Nutr 2003. 22: 283-289. (Science
Daily report)
Rapid Diagnosis of Active Tuberculosis by Detecting Antibodiesfrom Lymphocyte
Secretions Raqib R, et al. JID
2003;188:364-370
Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal
Recommended Doses of ACE Inhibitor in Diabetic Nephropathy: A randomized
double-blind crossover trial Rossing,K, et al. Diabetes
Care. 2003;26:2268-2274 (CME
Medscape)
Relation of aggressiveness of lipid-lowering treatment to changes in calcified
plaque burden by electron beam tomography. Hecht HS and Harman SM. Am
J Cardiol 2003;92:334-336.
REVIEW: Regulation of Nitric Oxide-Sensitive Guanylyl Cyclase Friebe A
AND and Koesling D. Circ
Res 2003 93: 96 - 105
Sexual Function in Men Older Than 50 Years of Age: Results from the Health
Professionals Follow-up Study. Bacon CG, et al.Ann
Intern Med. 2003;139:161–168.
Effects of Losartan or Atenolol in Hypertensive Patients without Clinically
Evident Vascular Disease: A Substudy of the LIFE Randomized Trial Devereux
RB, et al. Ann
Intern Med. 2003;139:169–177.
The Effect of Selective Intestinal Decontamination on the Hyperdynamic
Circulatory State in Cirrhosis. A Randomized Trial Rasaratnam B, et al. Ann
Intern Med. 2003;139:186–193.
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth
Factor Antibody, for Metastatic Renal Cancer. Yang, JC, et al.N Engl
J Med 2003; 349:427-434
The von Hippel–Lindau Protein, Vascular Endothelial Growth Factor,
and Kidney Cancer. George DJ and Kaelin WG. N
Engl J Med 2003; 349:419-421
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol
Therapy. Teng M, et al., N
Engl J Med 2003; 349:446-456
From the AMA:
The Physician's Guide to Assessing and Counseling Older Drivers
Relationship Between Periodontal Disease, Tooth Loss, and Carotid Artery
Plaque. The Oral Infections and Vascular Disease Epidemiology Study (INVEST)
Desvarieux M, et al. Stroke
published online July 31, 2003, 10.116
August 4
The Impact of Health Information on the Internet on the Physician-Patient
Relationship: Patient Perceptions. Murray E, et al. Arch
Intern Med. 2003;163:1727-1734.
Predictors of Warfarin Use Among Ohio Medicaid Patients With New-Onset
Nonvalvular Atrial Fibrillation Johnston JA, et al. Arch
Intern Med. 2003;163:1705-1710.
Pulmonary Embolism Mortality in the United States, 1979-1998: An Analysis
Using Multiple-Cause Mortality Data Horlander KT, et al.Arch
Intern Med. 2003;163:1711-1717.
August 1
"Inappropriate" Treatment Near the End of Life: Conflict Between
Religious Convictions and Clinical Judgment. Brett AS, ET AL. Arch
Intern Med. 2003;163:1645-1649.
Initial and Maintenance Naltrexone Treatment for Alcohol Dependence Using
Primary Care vs Specialty Care: A Nested Sequence of 3 Randomized Trials Arch
Intern Med. 2003;163:1695-1704.
Selecting Asymptomatic Patients for Coronary Computed Tomography or Electrocardiographic
Exercise Testing Greenland P and Gaziano JM, N
Engl J Med 2003;349:465-473
Medscape Reviews: Gene
Profiling of Lymphoma, Myeloma, and AML Lars Rogge, PhD, Elisabetta Bianchi,
MD, PhD
Promotion of G i3 subunit down-regulation by GIPN, a putative E3 ubiquitin
ligase that interacts with RGS-GAIP Fischer T et al. PNAS
2003 100: 8270-8275 (ScienceDaily
report Researchers Determine Mechanism For Degradation Of G Proteins)